Cardiac safety in a phase II study of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy for early-stage HER2-positive breast cancer Meeting Abstract
| Authors: | Dang, C. T.; Gianni, L.; Romieu, G.; Dirix, L.; Campone, M.; Citron, M. L.; Zamagni, C.; Krop, I. E.; Xu, N.; Smitt, M.; Suter, T. |
| Abstract Title: | Cardiac safety in a phase II study of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy for early-stage HER2-positive breast cancer |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009800125 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.532 |
| Notes: | Meeting Abstract: 532 -- Source: Wos |
